As of Tuesday, Structure Therapeutics Inc ADR’s (NASDAQ:GPCR) stock closed at $35.52, down from $35.59 the previous day. While Structure Therapeutics Inc ADR has underperformed by -0.20%, investors are advised to look at stock chart patterns for technical insight.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

On October 19, 2023, JMP Securities started tracking Structure Therapeutics Inc ADR (NASDAQ: GPCR) recommending Mkt Outperform.

Analysis of Structure Therapeutics Inc ADR (GPCR)

One of the most important indicators of Structure Therapeutics Inc ADR’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. Taking into account the quick ratio of the company, currently set at 10.45, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

For any stock, average volume can also provide valuable insight into volatility, and GPCR is recording 1.24M average volume. On a monthly basis, the volatility of the stock is set at 10.61%, whereas on a weekly basis, it is put at 13.32%, with a gain of 5.00% over the past seven days. Furthermore, long-term investors anticipate a median target price of $82.67, showing growth from the present price of $35.52, which can serve as yet another indication of whether GPCR is worth investing in or should be passed over.

How Do You Analyze Structure Therapeutics Inc ADR Shares?

Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 7.82%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 81.41% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

Are institutional investors increasing their holdings in GPCR shares?

The recent increase in stakes in GPCR appears to be a result of several institutional investors and hedge funds increasing their positions. T. Rowe Price Associates, Inc.’s position in GPCR has increased by 41.74% in the first quarter. The company now owns 2,513,563 shares of the stock, with a value of $139.98 million, following the purchase of 740,213 additional shares during the last quarter. Driehaus Capital Management LLC made another increased to its shares in GPCR during the first quarter, upping its stake by 110.30%. During the last quarter, the company picked up 1,252,940 additional shares for a total stake of worth $133.04 million, bringing number of shares owned by the company to 2,388,876.

During the first quarter, Janus Henderson Investors US LLC added a 1,934,693 position in GPCR. Deep Track Capital LP sold an additional -0.73 million shares in the last quarter, decreasing its holdings by -27.65%, now holding 1.92 million shares worth $106.65 million. At the end of the first quarter, Adage Capital Management LP increased its GPCR holdings by 835.52% and now holds 1.8 million GPCR shares valued at $100.24 million with the added 1.61 million shares during the period. GPCR shares are owned by institutional investors to the tune of 81.41% at present.

Leave a Reply

Your email address will not be published. Required fields are marked *